Back

Comparisons of clinical and economic outcomes between non-VKA oral anticoagulants among non-valvular atrial fibrillation patients: the ARISTOPHANES study

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Health economics Health Economics ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Xiaoyan Li

Princeton (United States of America)

9 More presentations in this session

Presentation thumbnail
Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe
Professor K. Kotseva (London, GB)
Abstract Slides
Presentation thumbnail
Cost-effectiveness of canakinumab to prevent recurrent cardiovascular events
Doctor T. Sehested (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Cost comparison of transfemoral aortic valve replacement with balloon-expandable prosthesis performed in a reduced versus extended heart team
Doctor M. Droppa (Tuebingen, DE)
Abstract
Presentation thumbnail
Sodium nitrite-mediated cardioprotection in primary percutaneous coronary intervention for ST-elevation myocardial infarction: a cost-effectiveness analysis
Doctor D. Jones (London, GB)
Abstract
Presentation thumbnail
Is trancatheter aortic valve replacement a profitable procedure in a high-volume european hospital?
Doctor F. Huchet (Saint-Nazaire, FR)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 3 - Health economics

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
The cost-effectiveness of a digitally enabled telerehabilitation program delivered nationally to patients in Australia
thumbnail
Congress Session
Evolutions in arrythmia and syncope management
thumbnail
Congress Session
How to implement a successful telemedicine program in heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources